红桃K品牌怎么样 申请店铺

红桃K集团公司成立于1994年6月，是国家科学技术部评定的重点高新技术企业集团，是湖北武汉生物技术产业的龙头企业。红桃K集团产业发展方向是以中国丰富的植物资源为本，以现代生物技术为体的大健康产业，包括中药现代化、药食同源保健食品、生物医药材料、内服外用化妆品等生物医药产业，以及生物农药、生物兽药、生物饲料、植物基因等生物农业产业。公司主导产品红桃K生血剂是诺贝尔奖成果转化产品，销售连续8年位居全国同行业第一，市场拓展和销售能力居于全国同行业前列。   红桃K集团以中药现代化、药食同源保健食品为产业发展方向。公司主导产品红桃K生血剂是诺贝尔奖成果转化产品，连续11年销售居全国同行业第一，总营销收入达78亿元，产品已拥有1亿多人次服用，被消费者誉为“中国血健康专家”。红桃K已累计向国家交税8.59亿元，多次受到湖北省、武汉市和东湖高新区重奖。   “红桃K”商标被国家认定为“中国驰名商标”；公司被国家工商总局列为“重合同守信用”企业；红桃K集团技术中心是国家发改委等四部委认定的国家级企业技术中心；公司被国家质量监督检验总局评选为“重质量守信誉”企业。   位于中国武汉光谷的红桃K药业基地，列入武汉市“十五”发展规划的重点项目，总占地面积350亩。药业基地一期工程投资3.6亿元，已建成投入使用，拥有符合GMP标准厂房的固体制剂车间、生物制剂车间、口服液车间和丸剂车间以及原料提取车间等，全部生产和检测设备从德国、意大利、英国引进，达到当今世界制药行业先进水平。   十多年来，红桃K集团开发现代保健中药，目前拥有国家新药和保健食品102个，其中国家新药7个，独家生产及传统中药74个，保健品转药品5个，保健食品16个，形成了补血类“红桃K”品牌、调经养颜类“经悦”品牌、补肾强身类“欢快”品牌等系列产品，形成了中国补血市场的技术核心竞争力，确立了在中国保健品行业的领导品牌地位。   红桃K集团先后盘活19家国有企业10多亿国有资产存量，并通过资本、技术、管理、新机制的注入，使这些国有企业脱困致富，焕发了生机和活力。自1994年至今，先后安置再就业人员18，568人，员工遍布全国各地。   红桃K回报社会为社会公益事业捐资1.12亿元，其中扶贫资金1500万元，热心支持知识工程、见义勇为、残疾人康复、抗洪救灾、市政建设、资助贫困失学儿童、建立优秀大学生奖学金、建设希望学校、支持体育事业、支持抗击非典等社会公益事业。   红桃K集团公司董事长谢圣明是一位学者型企业家。他原是湖北高校青年教师，1988年创办文化产业，1994年创建红桃K集团。十多年来，谢圣明艰苦创业，不断改革创新，对社会主义市场经济条件下民营企业持续发展作了有益探索，受到中央和湖北省、武汉市各级政府的重视。他连续当选九届、十届全国人大代表，当选两届全国工商联常委、湖北省工商联副会长。

Founded in June 1994, the company is a key high-tech enterprise group evaluated by the Ministry of science and technology of the people's Republic of China and a leading enterprise in the biotechnology industry in Wuhan, Hubei Province. The industrial development direction of red peach K group is a large-scale health industry based on China's rich plant resources and modern biotechnology, including the modernization of traditional Chinese medicine, medicine and food homologous health food, biomedical materials, cosmetics for internal and external use and other biomedical industries, as well as biological agricultural medicine, biological veterinary medicine, biological feed, plant gene and other biological agricultural industries. The company's leading product, red peach K blood generating agent, is a Nobel Prize achievement transformation product. Its sales rank first in the same industry in China for 8 consecutive years, and its market expansion and sales ability rank first in the same industry in China. Hongtao K group takes the modernization of traditional Chinese medicine and health food as its industrial development direction. The company's leading product, red peach K blood generating agent, is a product transformed from Nobel Prize achievements. For 11 consecutive years, it ranks first in the same industry in China, with a total marketing revenue of 7.8 billion yuan. The product has been taken by more than 100 million people, and is known as "Chinese blood health expert" by consumers. Hongtao K has paid a total of 859 million yuan of tax to the state, and has been awarded many times by Hubei Province, Wuhan city and Donghu high tech Zone. "Hongtao K" trademark is recognized as "China's famous trademark" by the state; the company is listed as "contract abiding and credit abiding" enterprise by the State Administration for Industry and commerce; the technology center of Hongtao K group is a national enterprise technology center recognized by four ministries and commissions including the national development and Reform Commission; the company is selected as "quality abiding and credit abiding" enterprise by the State Administration of quality supervision and inspection. Hongtao K pharmaceutical base, located in Optics Valley, Wuhan, China, is listed as the key project of Wuhan's "Tenth Five Year Plan" development plan, covering a total area of 350 mu. The first phase project of the pharmaceutical base has an investment of 360 million yuan. It has been completed and put into use. It has solid preparation workshop, biological preparation workshop, oral liquid workshop, pill workshop and raw material extraction workshop that meet GMP standard. All production and testing equipment are imported from Germany, Italy and the United Kingdom, reaching the advanced level of the pharmaceutical industry in the world. Over the past ten years, Hongtao K group has developed modern health care traditional Chinese medicine. At present, it has 102 national new drugs and health food, including 7 national new drugs, 74 exclusive and traditional traditional Chinese medicine, 5 health products transferred to drugs, 16 health food. It has formed a series of products, such as "Hongtao K" brand of blood tonifying, "Jingyue" brand of regulating menstruation and beautifying, and "huankuai" brand of kidney tonifying and body strengthening The technology core competitiveness of China's blood supply market has been established, and the leading brand position in China's health product industry has been established. Hongtao K group successively enlivened the stock of more than 1 billion state-owned assets of 19 state-owned enterprises, and through the injection of capital, technology, management and new mechanism, these state-owned enterprises got rid of difficulties and became rich, which gave them vitality and vigor. Since 1994, 18568 reemployees have been resettled, with employees all over the country. Hongtao K has donated 112 million yuan to social public welfare undertakings, of which 15 million yuan is for poverty alleviation. It is enthusiastic to support knowledge engineering, courage for good, rehabilitation of disabled people, flood relief, municipal construction, funding for poor out of school children, establishing scholarship for excellent college students, building hope schools, supporting sports undertakings, supporting the fight against SARS and other social public welfare undertakings. Xie Shengming, chairman of Hongtao K group, is a scholar entrepreneur. He was a young teacher in Hubei University. He founded the cultural industry in 1988 and the K group in 1994. Over the past ten years, Xie Shengming has worked hard to start his own business, made constant reform and innovation, and made a beneficial exploration of the sustainable development of private enterprises under the condition of socialist market economy, which has attracted the attention of the central government, Hubei Province and Wuhan municipal governments at all levels. He was elected as a deputy to the ninth and Tenth National People's Congress, a member of the Standing Committee of the all China Federation of industry and Commerce and vice president of Hubei Federation of industry and commerce.

本文链接： https://brand.waitui.com/9378c0617.html 联系电话：400-736-7177